STERIS WORKSHOP Disinfectant Validation and Efficacy Testing

24 Feb 2022
9.30-11.00 am SGT | Online
This presentation covers:
- Current debates in the industry regarding disinfectant coupon testing.
- PDA Technical Report No. 70 and USP 43 1072 in relation to current industry disinfectant efficacy testing.
- Recent FDA Warning Letters and 483s highlighting regulator expectations in disinfectant efficacy testing.
- Data will be presented on the importance of disinfectant efficacy testing with specific bacterial spores which can be more difficult to kill than ATCC strains.
- Both sides of the debate on disinfectant validation detailed with emphasis on current FDA, MHRA, ANVISA, ANSM, CFDA, and HPRA regulatory expectations and reducing the costs for testing.
- The recent PDA Technical Report No. 70 recommendations on DET.
Speakers:
• Jim Polarine Jr. MA., Senior Technical Service Manager at STERIS
• Richard Chai, Technical Service Manager at STERIS